Overweight in childhood cancer survivors: the Swiss Childhood Cancer Survivor Study. by Belle, F.N. et al.
   
 
 
 
 
Serveur Acade´mique Lausannois SERVAL serval.unil.ch
Author Manuscript
Faculty of Biology and Medicine Publication
This paper has been peer-reviewed but does not include the final publisher
proof-corrections or journal pagination.
Published in final edited form as:
Title: Overweight in childhood cancer survivors: the Swiss Childhood
Cancer Survivor Study.
Authors: Belle FN, Weiss A, Schindler M, Goutaki M, Bochud M,
Zimmermann K, von der Weid N, Ammann RA, Kuehni CE
Journal: The American journal of clinical nutrition
Year: 2018 Jan 1
Issue: 107
Volume: 1
Pages: 3-11
DOI: 10.1093/ajcn/nqx006
In the absence of a copyright statement, users should assume that standard copyright protection applies, unless the article contains
an explicit statement to the contrary. In case of doubt, contact the journal publisher to verify the copyright status of an article.
1 
 
 
 
TITLE PAGE 
 
Title: Overweight in childhood cancer survivors: the Swiss Childhood Cancer Survivor Study 
Author Names: Fabiën N. Belle, Annette Weiss, Matthias Schindler, Myrofora Goutaki, 
Murielle Bochud, Karin Zimmermann, Nicolas von der Weid, Roland A. Ammann, Claudia E. 
Kuehni for the Swiss Pediatric Oncology Group (SPOG)** 
Author Affiliations: Institute of Social and Preventive Medicine, University of Bern, 
Switzerland (FNB, AW, MS, MG, CEK); Institute of Social and Preventive Medicine 
(IUMSP), Lausanne University Hospital (CHUV), Switzerland (FNB, MB); Children’s 
Research Center, University Children’s Hospital Zürich, University of Zurich, Switzerland 
(KZ); University Children’s Hospital Basel (UKBB), University of Basel, Switzerland 
(NvdW); Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, 
Switzerland (RAA); Children’s University Hospital of Bern, University of Bern, Switzerland 
(CEK) 
** Swiss Pediatric Oncology Group (SPOG) Scientific Committee: Prof. Dr. med. R. Ammann, 
Bern; Dr. med. R. Angst, Aarau; Prof. Dr. med. M. Ansari, Geneva; Prof. Dr. med. M. Beck 
Popovic, Lausanne; Dr. med. P. Brazzola, Bellinzona; Dr. med. J. Greiner, St. Gallen; Prof. Dr. 
med. M. Grotzer, Zurich; Dr. med. H. Hengartner, St. Gallen; Prof. Dr. med. T. Kuehne, Basel; 
Prof. Dr. med. K. Leibundgut, Bern; Prof. Dr. med. F. Niggli, Zurich; PD Dr. med. J. 
Rischewski, Lucerne; Prof. Dr. med. N. von der Weid, Basel. 
Authors’ last names: Belle, Weiss, Schindler, Goutaki, Bochud, Zimmermann, Von der Weid, 
Ammann, Kuehni 
Corresponding author: Claudia E. Kuehni; Institute of Social and Preventive Medicine, 
University of Bern, Finkenhubelweg 11, 3012, Bern, Switzerland; Phone: +41 31 631 35 07; 
E-mail: claudia.kuehni@ispm.unibe.ch  
2 
 
 
 
Sources of support: This study is supported by the Swiss Cancer Research (KLS-3412-02-
2014, and KLS-3644-02-2015) and the Foundation Force, CHUV, Lausanne, Switzerland. The 
work of the Swiss Childhood Cancer Registry is supported by the Swiss Pediatric Oncology 
Group (www.spog.ch), Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen 
und –direktoren (www.gdk-cds.ch), Swiss Cancer Research (www.krebsforschung.ch), 
Kinderkrebshilfe Schweiz (www.kinderkrebshilfe.ch), the Federal Office of Health (FOH), and 
the National Institute of Cancer Epidemiology and Registration (www.nicer.org). MG is 
supported by national funding from the Swiss National Science Foundation 
(SNF320030_173044). 
Short running head: Overweight in Childhood Cancer Survivors 
Abbreviations: ALL, acute lymphoblastic leukemia; BMI, body mass index; CCS, childhood 
cancer survivors; CI, confidence interval; CNS, central nervous system; CRT, cranial radiation 
therapy; Dx, diagnosis; Gy, gray; HSCT, hematopoietic stem cell transplantation; ICCC-3, 
International Classification of Childhood Cancer, 3rd edition; IQR, interquartile range; OR, 
odds ratio; SCCR, Swiss Childhood Cancer Registry; SCCSS, Swiss Childhood Cancer 
Survivor Study; SHS, Swiss Health Survey 
ClinicalTrials.gov identifier: NCT03297034 
3 
 
 
 
ABSTRACT  1 
Background: An increased risk of becoming overweight has been reported for childhood 2 
cancer survivors (CCS), in particular leukemia survivors, though the evidence is inconclusive. 3 
Objectives: We assessed the prevalence of overweight in CCS, with a focus on leukemia 4 
survivors, compared it to peers and determined potential risk factors. 5 
Design: As part of the Swiss Childhood Cancer Survivor Study, we sent a questionnaire 6 
between 2007-2013 to all Swiss resident CCS age <21 years at diagnosis who had survived ≥5 7 
years. We calculated body mass index from medical records at diagnosis and self-reported 8 
heights and weights at survey. We calculated BMI z-scores using Swiss references for children, 9 
compared overweight prevalence in CCS, their siblings, and the general population using the 10 
Swiss Health Survey (SHS), and assessed risk factors for being overweight using multivariable 11 
logistic regression.  12 
Results: The study included 2,365 CCS, 819 siblings, and 9,591 SHS participants. At survey, 13 
on average 15 years after diagnosis, overweight prevalence in CCS overall (26%) and in 14 
leukemia survivors (26%) was similar to that of siblings (22%) and the general population 15 
(25%). Risk factors for being overweight in CCS were male sex (OR=1.8, 95%CI 1.5, 2.1), 16 
both young (OR5-14yrs=1.6, 1.2, 2.3) and older age at study (range OR25-29yrs=1.7, 1.2, 2.4; OR40-17 
45yrs=4.0, 2.5, 6.5), lower education (OR=1.4, 1.1, 1.8), migration background (OR=1.3, 1.1, 18 
1.7), and no sports participation (OR=1.4, 1.1, 1.7). Risk factors for overweight were similar in 19 
peers. CCS treated with cranial radiotherapy (≥20 gray) were more likely to be overweight than 20 
their peers (OR=1.6, 1.2, 2.2). 21 
Conclusion: Prevalence and risk factors for being overweight are similar in long-term CCS and 22 
their peers. This suggests that prevention methods can be the same as in the general population. 23 
An important exception is CCS treated with cranial radiotherapy ≥20 gray who may need extra 24 
attention during follow-up care. 25 
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Keywords: overweight, obesity, late effects, childhood cancer survivors, leukemia, Swiss 26 
Childhood Cancer Registry, Europe  27 
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INTRODUCTION  28 
Overweight and obesity are well-known risk factors for chronic diseases such as diabetes, 29 
dyslipidemia, hypertension, and cardiovascular disease (1). Fortunately, these risk factors are 30 
modifiable: primary and secondary prevention methods can reduce morbidity and mortality. 31 
Childhood cancer survivors (CCS) already have an elevated burden of chronic diseases due to 32 
cancer treatment, which rises with age (2, 3). It is thus important to avoid additional, 33 
preventable risk factors like obesity by identifying CCS at high risk and offering them targeted 34 
interventions. 35 
Whether CCS are more overweight in the long term after treatment is not clear. Two 36 
meta-analyses suggested that obesity was more common in childhood acute lymphoblastic 37 
leukemia (ALL) survivors within five years of treatment (BMI z-score, 0.89), but obesity 38 
diminished 5–9 years post-treatment (BMI z-score, 0.64) compared to healthy peers (4, 5). 39 
Results are inconclusive for those ≥10 years post-treatment, although overweight prevalence 40 
(34-46%) in these long-term ALL survivors seemed to be similar to that in noncancer 41 
comparison groups (4). Risk factors for overweight in the general population are sedentary 42 
lifestyle, low (≤2.5 kg) and high (>4 kg) birth weights (6, 7), and overweight during early 43 
childhood (8). In CCS most risk factors were the same as in the general population, but no study 44 
has considered birth weight. ALL and lymphoma survivors who have been overweight at 45 
diagnosis were substantially more likely to be overweight or obese 12 years after treatment (9). 46 
The same was true for cranial radiotherapy (CRT); ALL survivors treated with CRT were more 47 
likely to be overweight or obese than their siblings 21-25 years after diagnosis (10, 11). 48 
Studies of overweight conducted to date have been of somewhat limited relevance to 49 
childhood cancer survivors. Research on overweight prevalence has involved mostly ALL 50 
survivors (9-19), while study of risk factors has led to inconsistent conclusions (4). Studies 51 
conducted in the US reflect the lifestyles and eating habits of CSS in that country (10-13, 16, 52 
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17, 19-22), while the duration of follow-up in other studies has been only short to medium-term 53 
(4, 5), and many have had small (<250) sample sizes (4, 11, 13-15, 17-19). With this 54 
background of research in mind, we analyzed data from the Swiss Childhood Cancer Survivor 55 
Study (SCCSS) to 1) assess overweight prevalence in CCS overall and for specific, different 56 
diagnoses, 2) compare overweight prevalence in CCS to that of their siblings and the Swiss 57 
general population, and 3) identify sociodemographic and clinical risk factors for excessive 58 
weight. 59 
 60 
METHODS 61 
Study populations 62 
The Swiss Childhood Cancer Survivor Study (SCCSS)  63 
The SCCSS is a population-based, long-term follow-up study of all childhood cancer patients 64 
registered in the Swiss Childhood Cancer Registry (SCCR, www.childhoodcancerregistry.ch) 65 
who have been diagnosed with leukemia, lymphoma, central nervous system (CNS) tumors, 66 
malignant solid tumors, or Langerhans cell histiocytosis; survived ≥5 years after initial 67 
diagnosis of cancer; were under the age of 21; and were alive at the time of the study (23-25). 68 
Ethical approval of the SCCR and the SCCSS was granted by the Ethics Committee of the 69 
Canton of Bern (KEK-BE: 166/2014). 70 
 As part of the SCCSS, we traced all addresses of CCS diagnosed between 1976 and 71 
2005, and sent them a questionnaire between 2007 and 2013. Nonresponders received a second 72 
copy of the questionnaire four to six weeks later. If they again did not responded, we contacted 73 
them by phone. Our questionnaire included core questions from the US and UK CCS studies 74 
(26, 27), with added questions about health behaviors and sociodemographic measures from 75 
the Swiss Health Survey (SHS) (28) and the Swiss Census (29). The main domains covered by 76 
the questionnaire were quality of life, somatic health, fertility, current medication and health 77 
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services use, psychological distress, health behaviors, and socioeconomic status. Detailed 78 
information on our study design was published previously (23).  79 
 80 
Comparison groups 81 
We used two comparison groups for this study: siblings of the CCS and a random sample of the 82 
general Swiss population represented by data from the SHS. The sibling survey was conducted 83 
from 2009 to 2012. We asked CCS for consent to contact siblings and for their contact 84 
information. We have sent siblings the same questionnaire as CCS, omitting questions about 85 
cancer history. Siblings who did not responded received another copy of the questionnaire four 86 
to six weeks later, but were not contacted by phone (23). The second comparison group 87 
consisted of participants in the SHS survey 2012 (30). SHS is a representative national 88 
telephone survey repeated every five years. The SHS compiled a randomly selected 89 
representative sample of Swiss households with landline telephones, and attempted to contact 90 
one person per household. Sampling was stratified by region and conducted in a stepwise 91 
manner. Households were selected first, and then the survey was administered to anyone 15 or 92 
older who answered the phone.  93 
 94 
Measurements  95 
Body weight and BMI 96 
We obtained information on participants’ weight and height. For all CCS and both comparison 97 
groups, we had information on weight and height at time of survey from the self-administered 98 
questionnaires. Study participants were instructed to record height without shoes and weight 99 
without clothes. For leukemia survivors diagnosed between 1990 and 2005 and treated in a 100 
specialized pediatric cancer clinic, we also had information on weight and height at diagnosis 101 
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and at birth. Weight and height at diagnosis were obtained via a retrospective medical record 102 
audit. We obtained 98% of birth weights by using a probabilistic linkage procedure (G-LINK 103 
2.3, Statistics Canada) to link CCS and anonymous birth statistics having no personal identifiers 104 
that was collected by the Swiss Federal Statistical Office. Information on gender, date of birth, 105 
first name, nationality, municipality of residence at birth, and parental birth dates was used for 106 
linking. The remaining birth weights, 2%, were obtained from medical records. We calculated 107 
BMI by dividing weight in kilograms by height in meters squared (kg/m2). BMI in adults was 108 
classified as underweight (<18.5 kg/m2), normal weight (≥18.5 to <25 kg/m2), or overweight 109 
(≥25 kg/m2) (1). As recommended for children ≤19 years, we calculated BMI z-scores using 110 
the latest available Swiss growth curves (31). BMI z-scores were classified as underweight (<-111 
2), normal weight (-2 to 1), or overweight (>1, for age over 5 years, >2 for age 5 years or less) 112 
(32). Birth weight was classified into three categories: low (<2,500 g), normal (2,500-4,000 g), 113 
and high (>4,000 g) (33). 114 
 115 
Risk factors for being overweight at time of survey 116 
For all three study populations, we assessed gender, age at survey, educational level, migration 117 
background, language region in Switzerland, and participation in sports at time of survey as 118 
potential sociodemographic risk factors for being overweight. Participants who were not Swiss 119 
citizens at birth, not born in Switzerland, or had at least one parent who was not a Swiss citizen 120 
were classified as having a migration background. We classified education using three 121 
categories: primary education (compulsory schooling only, ≤9 years), secondary education 122 
(vocational training, 10-13 years), and tertiary education (higher vocational training, college, 123 
or university degree). Sports participation was classified as sports if respondents reported 124 
engaging in a specific gym or sports activity for at least one hour per week, or no sports with 125 
less or no such participation.  126 
9 
 
 
 
For the CCS population, we extracted additional clinical information from the Swiss 127 
Childhood Cancer Registry (SCCR). This included information on cancer diagnosis and the age 128 
at diagnosis. Diagnosis was classified according to the International Classification of Childhood 129 
Cancer, 3rd Edition (34). Radiotherapy was classified as cranial radiotherapy if the survivor had 130 
received direct radiation to the brain and/or skull. Cumulative dosage of cranial radiotherapy 131 
was obtained from medical records and categorized as either <20 Gray (Gy) or ≥20 Gy. We 132 
also retrieved records on hematopoietic stem cell transplantation (HSCT), chemotherapy, and 133 
relapse during follow-up time.  134 
 135 
Statistical Analyses  136 
We included all participants in the SCCSS (CCS and their siblings) and the SHS (general 137 
population), who were aged ≤45 years at time of survey and who provided self-reported height 138 
and weight (Supplemental Figure 1). For better comparison between CCS and peers, we 139 
standardized comparison groups for gender, age at survey, migration background, and language 140 
region as previously described (35-37). The first step in our analyses was to assess the overall 141 
prevalence of overweight in CSS at survey and stratify diagnostic groups. We divided BMI into 142 
two categories: overweight (overweight and obesity) versus non-overweight (underweight and 143 
normal) as separate categories were small and logistic regression outcomes for the categories 144 
overweight and obesity were in the same direction and magnitude as for the category 145 
overweight or obesity combined. Then we compared the prevalence of overweight between 146 
CCS and comparison groups using chi-square tests. Finally, we determined risk factors for 147 
being overweight at survey within each group separately using multivariable logistic regression. 148 
We identified potential sociodemographic, lifestyle, and clinical risk factors and included them 149 
in uni- and multivariable logistic regressions. To test for statistical significance, we used 150 
likelihood ratio tests for unstandardized groups and Wald tests for standardized groups. We 151 
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investigated whether birth weight and BMI at diagnosis were additional risk factors for 152 
overweight at survey in a subgroup of leukemia survivors who had been diagnosed between 153 
1990 and 2005. Interaction terms were used to formally test differences in effects of risk factors 154 
between CCS and comparison groups. We also included both CCS and comparison groups in 155 
multivariable logistic regression models to investigate whether the risk for being overweight 156 
was similar between groups stratified for CRT. We used Stata software (version 14, Stata 157 
Corporation, Austin, Texas) for all statistical analysis.  158 
 159 
RESULTS 160 
Response rate and characteristics of the study populations 161 
Among 4,116 eligible CCS, we traced and contacted 3,577, of whom 2,527 returned a 162 
questionnaire. We excluded 119 questionnaires that did not report height and weight, and a 163 
further 43 from survivors who were over 45 years old. We thus included 2,365 CCS in this 164 
study, of whom 770 were leukemia survivors, 461 diagnosed between 1990 and 2005 165 
(Supplemental Figure 1). We received consent to contact 1,530 siblings, of whom 866 166 
returned the questionnaire; 27 were outside the age range and 20 did not report height and 167 
weight, thus 819 siblings were finally included in the analyses. Of 41,008 households surveyed 168 
in the general population (SHS), 21,597 households replied to the survey. In those responding 169 
households, 9,591 persons who were 45 years old or younger were included in the analysis. 170 
Among CCS, the most common cancers were leukemia (predominantly ALL with 88%), 171 
lymphoma, and CNS and renal tumors (Table 1). Median age at diagnosis was 7 (IQR 3–12) 172 
years for CCS overall and 5 (IQR 3–9) years for leukemia. The median time from diagnosis to 173 
survey was 15 (IQR 10–21) years for CCS overall and 16 (IQR 11–22) years for leukemia 174 
survivors. Most leukemia survivors got chemotherapy. Among the subgroup of leukemia 175 
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survivors diagnosed between 1990 and 2005, 10% had a high birth weight and 6% were 176 
overweight at diagnosis (Supplemental Table 1). 177 
Sociodemographic characteristics were mostly identical across CCS and the comparison 178 
groups. Fewer CCS than siblings had parents who completed tertiary education, though, and 179 
the education level of CCS was slightly lower than that of their peers (Table 2). CCS engaged 180 
in less sports than siblings, but more than the general population.  181 
 182 
Overweight prevalence among childhood cancer survivors and comparison groups 183 
Overall, the prevalence of overweight among CCS was 26% (median BMI>19yrs: 27, IQR 26-184 
30; median BMI Z-score≤19yrs: 1, IQR 1-2), which was similar to overweight prevalence in the 185 
comparison groups: 22% in siblings (p=0.07, median BMI>19yrs: 27, IQR 26-29; median BMI 186 
Z-score≤19yrs: 1, IQR 1-2), 25% in the general population (p=0.64, median BMI>19yrs: 27, IQR 187 
26-29; median BMI Z-score≤19yrs: 1, IQR 1-2). However, CCS diagnostic groups differed: 31% 188 
of CNS neoplasm survivors were overweight, while only 13% of neuroblastoma and 18% soft 189 
tissue sarcoma survivors were overweight; the prevalence differences were statistically 190 
significant (p-values <0.001, <0.001, and 0.04, respectively; Figure 1). The prevalence of 191 
overweight in leukemia survivors (26%) was similar to the average of all CCS.  192 
 193 
Risk factors for being overweight among childhood cancer survivors and comparison 194 
groups 195 
In a multivariable regression, we found associations between all sociodemographic factors and 196 
being overweight. In all three study populations, males, those who were older at survey, and 197 
those who did not take part in sport activities were more likely to be overweight (Table 3). Also 198 
associated with being overweight were lower education (CCS, leukemia survivors), migration 199 
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background (CCS, the general population), and living in the German-speaking part of 200 
Switzerland (siblings, the general population). Results of univariable logistic regression can be 201 
found in Supplemental Table 2.  202 
 Interaction tests (Supplemental Table 3), showed that most effects of 203 
sociodemographic factors did not differ between CCS and the comparison groups (all 204 
interaction p-values ≥0.05), suggesting that the direction and strength of the associations 205 
between these risk factors and overweight were similar. The only difference was the effect of 206 
gender, which was weaker in CCS (OR 1.7, 95% CI 1.45, 2.14) compared to the general 207 
population (OR 2.42, 2.16, 2.71; Table 3, Supplemental Table 3). Among clinical factors, 208 
only ≥20 Gy CRT was associated with overweight. After combining all diagnostic groups, we 209 
saw that CCS who got ≥20 Gy CRT of whom 29% was diagnosed with leukemia and 45% with 210 
CNS neoplasms, were around 1.5 times more likely to be overweight in comparison to their 211 
peers, (ORCCS vs siblings 1.5, 1.1, 2.2; OR CCS vs general population 1.6, 1.2, 2.2; Figure 2).  212 
 We found no association between being overweight at survey and birth weight 213 
(p=0.523) in a subgroup of 461 leukemia survivors diagnosed between 1990 and 2005. 214 
However, being overweight at diagnosis was associated with being overweight at survey (OR 215 
9.86, 3.97, 24.51) (Supplemental Table 4). Results of univariable logistic regression can be 216 
found in Supplemental Table 5. Of 27 leukemia survivors who were overweight at diagnosis, 217 
18 (67%) remained overweight at survey. 218 
 219 
DISCUSSION  220 
Principal findings 221 
At a median 15 years after cancer diagnosis, 26% of all childhood cancer survivors were 222 
overweight. This is a prevalence comparable to that of their healthy peers, but there were 223 
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differences between diagnostic groups. Survivors of CNS neoplasms were most likely to be 224 
overweight, whereas survivors of neuroblastoma and soft tissue sarcoma were least likely to be 225 
overweight. Sociodemographic factors for being overweight were similar in CCS, their siblings, 226 
and the general population. Among clinical factors, we confirmed that ≥20 Gy CRT was 227 
associated with being overweight. 228 
 229 
Strengths and limitations  230 
Height and weight at survey were self-reported; both under- and over-reporting could have 231 
occurred. However, since height and weight were self-reported in all study populations we 232 
expected the degree of nondifferential errors of BMI assessment to be similar across CCS and 233 
comparison groups. BMI calculations are practical and inexpensive measures of overweight 234 
and are therefore widely used in population-based studies, and BMI values derived from self-235 
reported height and weight can be as reliable as measured values in the estimation of health 236 
risks (38). Prevalence of overweight might be underestimated as having a higher BMI at 237 
diagnosis is associated with a poorer survival. This could have resulted in more exclusion of 238 
overweight CCS due to our exclusion criteria of ≥5 years survival after initial diagnosis of 239 
cancer (39). Furthermore, our results could have been biased by reverse causation, e.g. a lack 240 
of sport participation could have been due to overweight. 241 
Long-term follow-up is a strength of this study, as are the national coverage of the 242 
SCCSS and our high CCS response rate, which makes this the largest such study in Europe to 243 
date. We also had access to high quality clinical information extracted from the SCCR, 244 
including extended information about clinical factors, birth weight, and height and weight at 245 
diagnosis for a large subgroup of leukemia patients. The questionnaire also allowed us to assess 246 
a wide variety of sociodemographic factors. Finally, we included not one but two comparison 247 
groups: siblings of CCS (who share environmental factors with CCS), and the general 248 
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population with data derived from a population-based study performed simultaneously in 249 
Switzerland.  250 
 251 
Overweight prevalence: results in relation to other studies 252 
Studies investigating overweight or obesity among CCS other than ALL survivors are scarce. 253 
Meta-analyses have suggested that overweight or obesity is common among short-term ALL 254 
survivors who are still in childhood or early adolescence compared to reference populations (4, 255 
5), and potentially increased among late adolescent and adult long-term ALL survivors ≥15 256 
years at survey (40). In our study, prevalence of overweight among CCS overall and leukemia 257 
survivors was similar to that of the general population, but increased for CNS neoplasms. CNS 258 
neoplasm survivors are exposed to several risk factors e.g. CRT, hypothalamic tumors, and 259 
surgical damage that might lead to hypothalamic obesity, more research on adequate 260 
management is needed (41, 42). 261 
 A contributor to differences in overweight prevalence between our results and those of 262 
pertinent studies across the literature included in meta-analyses may be those studies’ lack of 263 
detailed treatment information on CRT and dose-dependent associations with overweight. Our 264 
findings do agree with those of a recent US-based study of 14,290 CCS (median 24 [5-39] years 265 
after diagnosis) and 4,031 siblings in which self-reported obesity in CCS and siblings was 266 
similar to our result, and the 4,100 survivors treated with ≥18 Gy of CRT were more likely to 267 
be obese (20). By way of contrast, a study of 7,195 survivors of a variety of cancer types ≥5 268 
years after diagnosis reported underweight in CCS treated for different cancers, including 269 
neuroblastoma and soft tissue sarcoma, when compared to the general population (22), and an 270 
increased likelihood of obesity was observed in both male and female ALL survivors who 271 
received CRT ≥ 20 Gy (12, 22). 272 
 273 
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Potential mechanisms and risk factors: results in relation to other studies 274 
CRT affects the hypothalamic-pituitary axis, which may lead to growth hormone deficiency 275 
and leptin insensitivity, which could in turn put CCS at risk for neuroendocrine abnormalities 276 
such as obesity (13). However, previous studies of overweight in CCS and CRT have shown 277 
mixed results that vary from weak to strong associations (4). Older studies usually showed a 278 
clear association between overweight and CRT (9, 10, 12, 14), whereas those with children 279 
treated more recently with no or lower dose CRT have shown a smaller effect (15-17, 43). We 280 
found an association only between ≥20 Gy CRT and overweight. Overall, CCS and leukemia 281 
survivors treated with ≥20 Gy CRT were more likely to be overweight, which suggests that ≥20 282 
Gy CRT is a risk factor for obesity in all CCS irrespective of the diagnosis. The positive 283 
association between CRT and obesity has also been seen in adult survivors of a variety of 284 
different childhood cancer types (22, 44). Although CRT was not stratified by dose level, 285 
survivors in these studies were diagnosed between 1970-1986 (22) and 1966-1996 (44) and the 286 
majority might have received high-dose CRT. 287 
 Female gender also has been reported as a risk factor for obesity in ALL adult survivors 288 
(10, 12, 22). We could not confirm this; on the contrary, we found that men were more likely 289 
to be overweight or obese. This was the same in our comparison groups. Two systematic 290 
reviews on overweight in CCS published in 2014 and 2015 report no conclusive effect due to 291 
gender (4, 5). This suggests that gender differences mainly reflect social and cultural 292 
differences. We also found that leukemia survivors who are overweight at diagnosis have a 293 
substantially higher risk of being overweight later in life. This is in line with previous 294 
observations of survivors of leukemia (11, 17-19) and other childhood cancers (44) and the 295 
general population, in all of whom overweight tends to track strongly throughout life (45). As 296 
in our study, others have found that more than two-thirds of ALL survivors who were 297 
overweight at diagnosis remained overweight at the end of, or after treatment (18, 19).  298 
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 299 
Implications and recommendations  300 
Overweight and obesity are associated with chronic diseases that are frequently seen among 301 
CCS: type II diabetes and cardiovascular disease (46, 47). Poor diet and a sedentary lifestyle 302 
could further increase these already elevated risks. Personal counseling should be offered to 303 
childhood cancer patients and their parents throughout treatment and beyond, and special 304 
attention should be given to patients with an increased BMI (48). However, counseling during 305 
this period, when patients and families face the crisis of a life-threatening illness and nutritional 306 
status is not a first priority, is challenging. Also, children may receive high steroid doses, which 307 
increases appetite and fatty tissue, and they may experience fatigue or be immobilized for some 308 
time, which reduces their physical activity. During clinical follow-up, special attention should 309 
focus on CNS tumor and leukemia survivors treated with ≥20 Gy CRT, who have the highest 310 
risk of becoming overweight. Follow-up services with multiprofession teams including 311 
physicians, dieticians, nurses, and physiotherapists might be a promising approach. 312 
 313 
Conclusion 314 
This national survey in Switzerland found that prevalence and risk factors for overweight were 315 
similar in CCS overall and healthy peers, suggesting that prevention methods and interventions 316 
can be the same as in the general population. Important exceptions are CCS treated with ≥20 317 
Gy CRT who may need extra attention during follow-up care. 318 
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TABLE 1. Clinical characteristics of childhood cancer survivors (CCS) 
and childhood leukemia survivors 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: CNS, central nervous system; ICCC3, International Classification of Childhood 
Cancer, 3rd edition; Gy, Gray; HSCT, hematopoietic stem cell transplantation 
1 n=3 missing (<1%)  
 CCS 
(n= 2,365) 
Leukemia 
(n= 770) 
Characteristics n   (%) n   (%) 
ICCC3 diagnosis 
  I: Leukemia 
  II: Lymphoma 
  III: CNS neoplasm 
  IV: Neuroblastoma 
  V: Retinoblastoma 
  VI: Renal tumor 
  VII: Hepatic tumor 
  VIII: Malignant bone tumor 
  IX: Soft tissue sarcoma 
  X: Germ cell tumor 
  XI & XII: Other tumor 
  Langerhans cell histiocytosis 
 
770  (33) 
424  (18)  
341  (14) 
118  (5) 
72    (3) 
144  (6) 
20    (1) 
96    (4) 
137  (6) 
106  (4) 
54    (2) 
83    (4) 
 
770 (100) 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Age at diagnosis, year 
  <5 
  ≥5 
 
1,413 (60) 
952    (40) 
 
389 (51) 
381 (49) 
Year of diagnosis 
  Before 1990 
  1990-2000 
  After 2000 
 
762 (32) 
977 (41) 
626 (26) 
 
291 (38) 
299 (39) 
180 (23) 
Time since diagnosis, median (IQR) 15.0 (10.0-20.9) 15.6 (10.7-22.0) 
Chemotherapy1 
  No 
  Yes 
 
509    (22) 
1,856 (78) 
 
- 
767 (100) 
Cranial radiation therapy (CRT) 
  No CRT 
  <20 Gy 
  ≥20 Gy 
 
1,950 (82) 
157    (7) 
258    (11) 
 
599 (78) 
95   (12) 
76   (10) 
Hematopoietic stem cell transplantation 
(HSCT)  
  No 
  Yes 
 
 
2,248 (95) 
117    (5) 
 
 
709 (92) 
61   (8) 
History of relapse 
  No 
  Yes 
 
2,081 (88) 
284    (12) 
 
670 (87) 
100 (13) 
23 
 
 
 
TABLE 2. General characteristics of childhood cancer survivors (CCS) and comparison groups  
 Childhood cancer 
survivors 
Siblings1 
(n =819) 
General 
population1 
(n =9,591)  CCS  
(n =2,365) 
Leukemia 
(n =770) 
Characteristics n (%)  n (%) n (%std) p-value2 n (%std) p-value2 
Gender 
  Female 
  Male 
 
1,086   (46) 
1,279   (54)  
 
367 (48) 
403 (52) 
 
473 (45) 
346 (55)       n.a. 
 
4,946 (46) 
4,645 (54)      n.a. 
Age at survey, year  
  5-14 
  15-19 
  20-24 
  25-29 
  30-34 
  35-39 
  40-45 
 
329   (14) 
541   (23) 
530   (22) 
401   (17) 
277   (12) 
185   (8) 
102   (4) 
 
121 (16) 
184 (24) 
167 (22) 
136 (18) 
87   (11) 
47   (6) 
28   (4) 
 
94   (18) 
142 (20) 
162 (19) 
168 (19) 
115 (12) 
84   (8) 
54   (5)         n.a. 
 
- 
1,518 (33) 
1,440 (23) 
1,174 (13) 
1,424 (11) 
1,601 (9) 
2,434 (10)      n.a. 
Parents’ education (highest 
degree)3 
  Primary schooling 
  Secondary education 
  Tertiary education 
 
 
62   (7) 
469 (54) 
339 (39) 
 
 
26   (9) 
165 (54) 
114 (37) 
 
 
8     (3) 
115 (47) 
113 (50)    0.007 
 
 
n.a. 
Personal education4 
  Primary schooling 
  Secondary education 
  Tertiary education 
 
117    (8) 
1,010 (68) 
368    (25) 
 
36   (8) 
337 (72) 
92   (20) 
 
24   (4) 
359 (61) 
200 (35)  <0.001 
 
691    (8) 
4,549 (62) 
2,833 (30)    <0.001 
Migration  
  No migration background 
  Migration background 
 
1,762 (75) 
603    (26) 
 
573 (74) 
197 (26) 
 
657 (75) 
162 (25)       n.a. 
 
6,137 (77) 
3,454 (23)      n.a. 
Language region of Switzerland 
  German speaking 
  French speaking 
  Italian speaking 
 
1,658 (70) 
630    (27) 
77      (3) 
 
571 (74) 
172 (22) 
27   (4) 
 
650 (70) 
143 (27) 
26   (3)         n.a. 
 
6,300 (70) 
2,620 (27) 
671    (3)        n.a. 
Sports 
  Yes 
  No 
 
1,623 (69) 
742    (31) 
 
544 (71) 
226 (29) 
 
593 (75) 
226 (25)    0.002 
 
5,598 (64) 
3,993 (36)  <0.001 
BMI at survey5 
  Underweight 
  Normal 
  Overweight 
 
127    (5) 
1,632 (69) 
606    (26) 
 
43   (6) 
525 (68) 
202 (26) 
 
20   (2) 
602 (76) 
197 (22)  <0.001 
 
349    (3) 
6,354 (72) 
2,888 (25)   <0.001 
Abbreviations: BMI, body mass index; Dx, diagnosis; n.a., not applicable 
1 Standardized on gender, age at survey, migration background and language region according to CCS 
2 p-value calculated from Chi-Square statistics comparing comparison group to CCS (2-sided test) 
3 Highest parental education level of CCS and siblings <20 years at time of survey 
4 Highest personal education level of CCS, siblings, and the general population ≥20 years at time of survey 
5 BMI Z-scores were calculated for CCS, siblings, and the general population ≤19 yrs, BMI scores (kg/m2) were calculated for adults 
(>19 yrs) 
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TABLE 3. Overweight prevalence and risk factors associated with overweight in childhood cancer survivors (CCS) or comparison 
groups (from multivariable logistic regression)  
 Childhood cancer survivors Siblings1 
(n =819) 
General population1 
(n =9,591) 
 CCS  
(n =2,365) 
Leukemia 
(n =770) 
  
 %ow2  OR (95% CI)    p-value3 %ow2  OR (95% CI)    p-value3 %ow2  OR (95% CI)       p-value4 %ow2 OR (95% CI)  p-value4 
Sociodemographic characteristics 
  Gender 
    Female 
    Male 
 
 
(20) 1.00 (ref)             <0.001 
(30) 1.76 (1.45, 2.14) 
 
 
(20) 1.00 (ref)             <0.001 
(32) 1.95 (1.38, 2.76) 
 
 
(17) 1.00 (ref)                 <0.001 
(27) 2.20 (1.51, 3.18) 
 
 
(17) 1.00 (ref)            <0.001 
(32) 2.42 (2.16, 2.71) 
  Age at survey, year 
    5-14  
    15-19  
    20-24 
    25-29 
    30-34 
    35-39 
    40-45 
 
(25) 1.64 (1.16, 2.32)  <0.001 
(17) 1.00 (ref)  
(21) 1.30 (0.94, 1.78) 
(25) 1.71 (1.24, 2.38) 
(34) 2.76 (1.94, 3.91) 
(43) 3.80 (2.58, 5.60) 
(41) 4.03 (2.50, 6.48) 
 
(29) 2.05 (1.16, 3.64)  <0.001 
(16) 1.00 (ref)  
(21) 1.25 (0.71, 2.20) 
(23) 1.62 (0.90, 2.90) 
(40) 3.64 (1.97, 6.70) 
(53) 6.13 (2.94, 12.78) 
(39) 3.81 (1.54, 9.42) 
 
(12) 1.48 (0.65, 3.36)      <0.001 
(11) 1.00 (ref)  
(20) 2.17 (1.07, 4.40) 
(25) 2.87 (1.49, 5.54) 
(34) 4.64 (2.33, 9.25) 
(43) 7.04 (3.40, 14.58) 
(46) 8.53 (3.65, 19.94) 
 
-                                 <0.001 
(16) 1.00 (ref)  
(23) 1.58 (1.30, 1.92) 
(28) 2.07 (1.70, 2.52) 
(31) 2.39 (1.98, 2.88) 
(37) 3.00 (2.50, 3.60) 
(41) 3.73 (3.15, 4.42) 
  Age at diagnosis, year 
    ≥5 
    <5 
 
(26) 1.00 (ref)               0.107 
(25) 1.20 (0.96, 1.49) 
 
(26) 1.00 (ref)               0.161 
(27) 1.29 (0.90, 1.86) 
 
n.a 
 
n.a 
  Education5 
    Primary schooling 
    Secondary education 
    Tertiary education  
 
(28) 1.45 (0.98, 2.15)   0.008 
(27) 1.42 (1.13, 1.78) 
(22) 1.00 (ref) 
 
(31) 2.06 (1.03, 4.12)   0.010 
(29) 1.88 (1.22, 2.89) 
(18) 1.00 (ref) 
 
(31) 1.75 (0.65, 4.72)        0.268 
(24) 1.36 (0.90, 2.05) 
(19) 1.00 (ref) 
 
n.a. 
  Migration 
    No migration background 
    Migration background 
 
(25) 1.00 (ref)               0.011 
(29) 1.34 (1.07, 1.68) 
 
(26) 1.00 (ref)               0.368 
(27) 1.21 (0.80, 1.81) 
 
(22) 1.00 (ref)                    0.189 
(23) 1.37 (0.86, 2.18) 
 
(23) 1.00 (ref)            <0.001 
(31) 1.34 (1.19, 1.50) 
  Language region of Switzerland 
    German speaking 
    French speaking 
    Italian speaking 
 
(26) 1.00 (ref)               0.287 
(24) 0.84 (0.67, 1.05) 
(25) 0.94 (0.55, 1.63) 
 
(27) 1.00 (ref)               0.638 
(25) 0.95 (0.63, 1.44) 
(19) 0.62 (0.22, 1.74) 
 
(25) 1.00 (ref)                    0.017 
(16) 0.46 (0.27, 0.79) 
(18) 0.69 (0.19, 2.46) 
 
(26) 1.00 (ref)              0.019 
(23) 0.85 (0.74, 0.96) 
(24) 0.84 (0.67, 1.04) 
  Sports 
    Yes  
    No 
 
(23) 1.00 (ref)               0.004 
(31) 1.35 (1.10, 1.66) 
 
(24) 1.00 (ref)               0.427 
(31) 1.17 (0.80, 1.70) 
 
(19) 1.00 (ref)                    0.002 
(34) 1.90 (1.27, 2.85) 
 
(23) 1.00 (ref)            <0.001 
(30) 1.42 (1.27, 1.60) 
1 Standardized on gender, age at survey, migration background, and language region according to CCS; multivariable logistic regressions are separately for each study 
population 
2 Column overweight percentages are given 
3 p-value calculated from likelihood ratio test 
4 Global p-value for an association between prevalence of overweight/obesity and the variables as a whole (Wald test comparing models with and without the variable) 
5 Highest parental (<20 years at time at survey) or personal education (≥20 years at time of survey) 
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FIGURE LEGENDS 
Figure 1: Overweight in childhood cancer survivors and comparison groups Abbreviations: CNS, 
central nervous system; LCH, Langerhans cell histiocytosis 
BMI distribution of comparison groups is standardized on gender, age at survey, migration 
background, and language region according to childhood cancer survivors. 
The dotted line reflects the overweight prevalence of the general population. 
 
Figure 2: Cranial radiation therapy-specific OR and 95%CI for overweight in childhood cancer 
survivors versus comparison groups (from multivariable logistic regression1, 2) Squares, OR for 
overweight; whiskers, the respective 95% CI 
Abbreviations: CI, confidence interval; CRT, cranial radiation therapy; Gy, gray  
1 Both comparison groups are standardized on gender, age at survey, migration background, and 
language region according to CCS 
2 Adjusted for gender, age, education, migration background, language region of Switzerland, and 
sports 
